Regulatory approval has now been obtained for all participating coutries.✔️
Since the beginning of the RITA-MI2 trial in 2022, 20 recruitment centres, in France, the UK, Germany, Spain and the Czech Republic have opened for recruitment. 👏
4 additional centres, in Germany, the Netherlands, the UK and the Czech Republic will follow this year.
The first patient has been included on the 1st June 2022 at Bichat Hospital, France, and recruitment has continued since then.🩺💉🩸
✨All teams are highly motivated for this important trial.✨
Way to go, all !